Gilead strategies to post lenacapavir for approval to be used as PrEP for the Food and Drug Administration by the end with the year. So this potent new HIV-prevention tool could strike the U.S. sector by mid-to-late https://europeantimes.news/2024/08/pope-francis-calls-on-religions-to-unite-to-reduce-demand-for-drugs/